Why payment evidence matters before medical travel
Medical tourism transactions can involve a clinic brand, facilitator, hotel, transfer provider, payment processor and overseas company. If something goes wrong, unclear payment trails make disputes harder. The patient needs evidence of the supplier, service, price, currency, refund rules and delivery obligation.
This does not mean every dispute will succeed. It means the patient is not relying on memory, screenshots without dates or verbal promises.
Section 75, chargeback and realistic expectations
The Financial Ombudsman explains that Section 75 is shorthand for part of the Consumer Credit Act and relates to certain credit arrangements. MoneySavingExpert and consumer guidance commonly distinguish Section 75 from chargeback, but eligibility can depend on amount, card type, supplier relationship, payment processor and evidence.
Patients should not assume card protection covers every overseas medical dispute. If payment protection matters, ask the card provider or consumer adviser before paying, and keep the direct supplier relationship as clear as possible.
Evidence folder before you pay
Create one folder with quote, package terms, doctor-role statement, graft estimate, cancellation/refund policy, invoice, payment link, payment recipient, card receipt, bank transfer proof, clinic legal name, hotel/transfer confirmations and aftercare promises. Save webpages as PDFs if claims are important.
Screenshots should show dates, sender identity and context. A cropped promise without the clinic name or date is weaker evidence.
Refund pressure and cancellation scenarios
Before paying, ask what happens if the clinic cancels, the doctor decides you are unsuitable, you become medically unfit, flights are disrupted, graft numbers change, or you refuse consent after seeing the final plan. These scenarios should not be improvised at reception.
If a provider says “refund guaranteed,” ask for the exact written trigger, timescale, deductions and payment route. A clear no-refund term is still useful because it lets you decide whether the commercial risk is acceptable.